Cortical Disarray Measurement (CDM) is a platform technology designed to assess Alzheimer’s disease at the cellular level, which is impossible to achieve with volumetric methods
We extract measurements directly from standard MRI/DTI data to provide an index linked to the micro-anatomical health of patients' brains
Our CDM software device provides unique insight into the point at which the disease materialises in the anatomy of the cerebral cortex
Our CDM Technology can identify the location and pattern of change in grey matter quality bringing a new level of diagnostic certainty beyond simple measures of quantity